Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.720
-0.020 (-1.15%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $73.36 million as of June 26, 2026. Its market cap has increased by 29.63% in one year.
Market Cap
73.36M
Enterprise Value
57.50M
1-Year Change
29.63%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $73.36M, a decrease of -41.14%. That is a compound annual growth rate of -9.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 73.36M | -40.76% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rallybio | 84.26M |
| Rein Therapeutics | 84.10M |
| MAIA Biotechnology | 83.91M |
| OKYO Pharma | 82.39M |
| Heron Therapeutics | 81.13M |
| OS Therapies | 81.06M |
| Gossamer Bio | 80.27M |
| LeonaBio | 77.68M |